PRO-PHARMACEUTICALS, INC. 8-K

Company

GALECTIN THERAPEUTICS INC

Filed

May 18, 2005

Period of Report

May 9, 2005

Accession Number

0001157523-05-004883

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →